Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Altered Lipid Metabolism in CNS Demyelination and Remyelination Are Key Elements Driving Progressive MS.

International journal of molecular sciences·2025
Same author

MIF functional polymorphisms are associated with acute GVHD progression and steroid-refractoriness.

Frontiers in immunology·2025
Same author

The CD74 inhibitor DRhQ improves short-term memory and mitochondrial function in 5xFAD mouse model of Aβ accumulation.

Metabolic brain disease·2025
Same author

<i>Centella asiatica</i> Promotes Antioxidant Gene Expression and Mitochondrial Oxidative Respiration in Experimental Autoimmune Encephalomyelitis.

Pharmaceuticals (Basel, Switzerland)·2025
Same author

CD74 promotes the formation of an immunosuppressive tumor microenvironment in triple-negative breast cancer in mice by inducing the expansion of tolerogenic dendritic cells and regulatory B cells.

PLoS biology·2024
Same author

MIF and CD74 as Emerging Biomarkers for Immune Checkpoint Blockade Therapy.

Cancers·2024

相关实验视频

Updated: Jul 11, 2025

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

12.3K

多发性硬化症的新疗法在EAE小鼠模型中保护白质功能.

Sarah Zerimech1, Hung Nguyen1, Arthur A Vandenbark2,3,4

  • 1Anesthesiology and Perioperative Medicine (APOM), Oregon Health and Science University, Portland, OR, United States.

Frontiers in molecular medicine
|November 7, 2023
PubMed
概括

一种新的治疗构造,DRhQ,在多发性硬化症 (MS) 的小鼠模型中进行了测试. DRhQ改善了轴突完整性和减少了炎症,为渐进式多发性硬化症治疗提供了潜在的可能性.

关键词:
在CAP CAP中,我们可以使用CAP.这就是DRHQ.星球细胞是星球细胞.轴子的功能是轴子的功能.微质细胞中的微质细胞骨髓蛋白是什么意思 骨髓蛋白是什么意思

更多相关视频

Myelin Oligodendrocyte Glycoprotein MOG35-55 Induced Experimental Autoimmune Encephalomyelitis EAE in C57BL/6 Mice
08:03

Myelin Oligodendrocyte Glycoprotein MOG35-55 Induced Experimental Autoimmune Encephalomyelitis EAE in C57BL/6 Mice

Published on: April 15, 2014

82.1K
Simple and Efficient Production and Purification of Mouse Myelin Oligodendrocyte Glycoprotein for Experimental Autoimmune Encephalomyelitis Studies
10:47

Simple and Efficient Production and Purification of Mouse Myelin Oligodendrocyte Glycoprotein for Experimental Autoimmune Encephalomyelitis Studies

Published on: October 27, 2016

11.0K

相关实验视频

Last Updated: Jul 11, 2025

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

12.3K
Myelin Oligodendrocyte Glycoprotein MOG35-55 Induced Experimental Autoimmune Encephalomyelitis EAE in C57BL/6 Mice
08:03

Myelin Oligodendrocyte Glycoprotein MOG35-55 Induced Experimental Autoimmune Encephalomyelitis EAE in C57BL/6 Mice

Published on: April 15, 2014

82.1K
Simple and Efficient Production and Purification of Mouse Myelin Oligodendrocyte Glycoprotein for Experimental Autoimmune Encephalomyelitis Studies
10:47

Simple and Efficient Production and Purification of Mouse Myelin Oligodendrocyte Glycoprotein for Experimental Autoimmune Encephalomyelitis Studies

Published on: October 27, 2016

11.0K

科学领域:

  • 神经科学是一个神经科学.
  • 免疫学 免疫学 免疫学
  • 病理学 病理学 病理学

背景情况:

  • 多发性硬化症 (MS) 是一种慢性脱髓化疾病,其特征是显著的轴突功能障碍.
  • 以前的研究表明,主要的组织相容性复杂II类结构可以通过抑制巨细胞迁移抑制因子 (MIF) 和细胞外信号调节激酶 (ERK) 激活来逆转实验性自身免疫脑膜炎 (EAE) 症状.
  • 这些结构还促进了复髓化,减少了炎症.

研究的目的:

  • 评估新型第三代结构DRhQ对EAE小鼠模型中轴突完整性的影响.
  • 评估DRhQ对不同白质区的髓和非髓轴突的影响.
  • 确定DRhQ对进展性多发性硬化症的治疗潜力,包括对缺血性脆弱性的影响.

主要方法:

  • 电生理学被用来比较EAE小鼠体切片和视神经中的轴突导电性质.
  • 该研究研究了EAE和DRhQ治疗对轴突刺激性,导电速度和时空总和的影响.
  • 研究了EAE模型中白质对缺血的易受性增加以及DRhQ的保护作用.

主要成果:

  • EAE诱导了轴突刺激能力的改变,延迟导电和减缓总和,与星球细胞和微质激活相关.
  • 在EAE发作后的DRhQ治疗显著抑制了微质细胞和天体细胞激活.
  • DRhQ的使用改善了髓化轴突的功能完整性,并增强了白质缺血的恢复.

结论:

  • 在EAE发作后进行的DRhQ治疗促进了白质的完整性和功能.
  • 在EAE MS模型中观察到的DRhQ减少了对缺血性损伤的易受性增加.
  • 这些发现表明DRhQ对于渐进的多发性硬化症具有显著的治疗潜力.